Novartis Faces Setback with MorphoSys Acquisition as Safety Concerns Delay Key Drug Approval Plans
In a turn of events that could reshape Novartis' $2.9 billion acquisition of German biotech MorphoSys, the Swiss pharmaceutical giant ...
Tag: Novartis
Monte Rosa Therapeutics Secures $150M Partnership with Novartis for Autoimmune Treatment
Monte Rosa Therapeutics, a Boston-based biotechnology firm, has struck a significant deal with Novartis, securing $150 million for its innovative ...
